Aligos Therapeutics Inc (ALGS)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
34,407,500
EV to revenue ratio (TTM)
0.249
EV to ebitda
0.575
Financial Performance
Revenue (TTM)
31,518,000
Gross profit (TTM)
-56,859,000
EBITDA
-77,916,000
Profitability
Operating margin (TTM)
-6.80%
Profit margin
-241.00%
Return on assets (TTM)
-49.10%
Return on equity (TTM)
-113.60%
Per Share Metrics
Revenue per share (TTM)
3.03
EPS
-7.71
Diluted EPS (TTM)
-7.71
Book value
5.11
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
1.092
Price to book ratio (TTM)
1.089
Growth
Quarterly earnings growth (YoY)
2,779.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
1
Buy
7
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
2.333